AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 46 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,000 | -2.8% | 14,900 | -1.7% | 0.02% | -11.1% |
| Q4 2018 | $36,000 | -21.7% | 15,150 | -9.0% | 0.02% | -28.0% |
| Q3 2018 | $46,000 | -79.6% | 16,650 | +5.0% | 0.02% | -75.5% |
| Q2 2018 | $226,000 | -50.0% | 15,850 | -50.0% | 0.10% | -23.9% |
| Q1 2018 | $452,000 | +128.3% | 31,700 | +100.0% | 0.13% | +44.1% |
| Q4 2017 | $198,000 | – | 15,850 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
| RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
| Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
| EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
| Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
| Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
| Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
| Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
| JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
| Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |